Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study

NCT02639039 | Completed Phase 4

• 1 other identifier: 110495
• Study Type: interventional
• Target: 50
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purpose of this study is to determine if trigger point dry needling (TDN) is as effective as cortisone injection (CI) in reducing pain and improving function in patients with greater trochanteric pain syndrome (GTPS).

Conditions

Hip Injuries

Outcome Measures

Primary Outcomes (2)

• Participants change in pain rating scores from baseline to 6 weeks will be accessed.

  Baseline and 6 weeks

• Patient specific function score (PSPS) from baseline to 6 weeks will be accessed.

  Baseline and 6 weeks

Study Arms (2)

Cortisone Injection

ACTIVE COMPARATOR

Fifty patients with GTPS will be randomized into a CI or TDN group. Treatment will be carried out at the 1st visit following consent according to SOC. Treatment will be administered according to standard of care for up to 6 weeks.

Drug: Cortisone Injection

Trigger Point Dry Needling

ACTIVE COMPARATOR

Fifty patients with GTPS will be randomized into a CI or TDN group. Treatment will be carried out at the 1st visit following consent according to SOC. Treatment will be administered according to standard of care for up to 6 weeks.

Procedure: Trigger Point Dry Needling

Interventions

Cortisone Injection DRUG

Exact location and technique of injection within the region of the involved greater trochanter will be determined by the provider. The number of f/u visits within 6 wks following initiation of treatment will be determined by the provider, but CI is the only treatment.

Also known as: Steroid injection

Cortisone Injection

Trigger Point Dry Needling PROCEDURE

Exact location of needle insertion, technique and number of penetrations within the region of the involved posterolateral hip will be determined by the provider. The number of f/u visits within 6 wks following initiation of treatment will be determined by the provider, but TDN is the only treatment.

Trigger Point Dry Needling

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• + years old
• lateral hip pain (anywhere from iliac crest to mid ITB)
• active email account

You may not qualify if:

• low back pain associated with the hip pain
• motor and/or sensory impairment consistent with radiculopathy
• active infection/malignancy of the hip
• connective tissue disease
• pregnancy
• non-English speaking

Sponsors & Collaborators

• Scott and White Hospital & Clinic: lead

Related Publications (1)

• Brennan KL, Allen BC, Maldonado YM. Dry Needling Versus Cortisone Injection in the Treatment of Greater Trochanteric Pain Syndrome: A Noninferiority Randomized Clinical Trial. J Orthop Sports Phys Ther. 2017 Apr;47(4):232-239. doi: 10.2519/jospt.2017.6994. Epub 2017 Mar 3.

  PMID: 28257614 DERIVED

MeSH Terms

Conditions

Hip Injuries

Interventions

Cortisone; Steroids

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Pregnenes; Pregnanes; Fused-Ring Compounds; Polycyclic Compounds; 17-Hydroxycorticosteroids; Hydroxycorticosteroids; Adrenal Cortex Hormones; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

• Kindyle L Brennan, PhD

  Orthopedic Therapist

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 2, 2015
• First Posted: December 24, 2015
• Study Start: February 1, 2013
• Primary Completion: July 1, 2015
• Study Completion: July 1, 2015
• Last Updated: December 29, 2015

Record last verified: 2015-12

Data Sharing

• IPD Sharing: Will not share